8 risultati
TECHNICAL FIELD
The current invention, according to some embodiments, relates to methods of using antioxidant compositions to prevent, reduce, or eliminate the negative effects of oxidative damage or inflammation. In particular embodiments, the antioxidant compositions may be used with soft oral
TECHNICAL FIELD
This invention pertains to substituted chalcones, specifically substituted 1-(4-methoxyphenyl)-3-(3,5-dimethoxyphenyl)prop-1-en-3-ones, which have therapeutic application, for example, as potent antiproliferative agents and antiinflammatory agents. The present invention also pertains
FIELD OF THE INVENTION
The present invention relates to chalcone and chalcone derivatives and analogs which are useful as angiogenesis inhibitors. The present compounds, which are inexpensive to synthesize exhibit unexpectedly good activity as angiogenesis inhibitors. The present invention also
FIELD OF THE INVENTION
The present invention relates to chalcone and chalcone derivatives and analogs which are useful as angiogenesis inhibitors. The present compounds, which are inexpensive to synthesize exhibit unexpectedly good activity as angiogenesis inhibitors. The present invention also
FIELD OF THE INVENTION
The present invention relates to chalcone and chalcone derivatives and analogs which are useful as angiogenesis inhibitors. The present compounds, which are inexpensive to synthesize exhibit unexpectedly good activity as angiogenesis inhibitors. The present invention also
FIELD OF THE INVENTION
The present invention relates to chalcone and chalcone derivatives and analogs which are useful as angiogenesis inhibitors. The present compounds, which are inexpensive to synthesize exhibit unexpectedly good activity as angiogenesis inhibitors. The present invention also
This application is the U.S. national phase of international application PCT/GB02/04462 filed 30 Sep. 2002 which designated the U.S. and claims benefit of GB 0123780.9, dated 3 Oct. 2001, the entire content of which is hereby incorporated by reference.
RELATED APPLICATION
This application is related
This application is the U.S. national phase of international application PCT/GB02/04406 filed 30 Sep. 2002 which designated the U.S. and claims benefit of GB 0123777.5, dated 3 Oct. 2001, the entire content of which is hereby incorporated by reference.
RELATED APPLICATION
This application is related